Classifying non-Hodgkin lymphoma (NHL) can be confusing because there are so many types. The World Health Organization system is often used. It groups NHL by the appearance of the lymphoma cells, the ...

Lymphoma is a type of cancer that begins in lymphocytes — the white blood cells that play a vital role in the immune system. These cells are located in areas such as the lymph nodes, spleen, thymus, ...

Lymphoma is a type of blood cancer that targets the lymphatic system. This type of cancer impacts the cells that are a part of one's immune system, according to the American Cancer Society. There are ...

Hodgkin’s lymphoma is a type of cancer that starts growing in the white blood cells of the immune system. There are two different types and five subtypes, each with different characteristics.

Anaplastic large cell lymphoma (ALCL) is a rare subtype of non-Hodgkin lymphoma and a form of T-cell lymphoma. Lymphoma is a type of cancer that affects lymphocytes, a type of white blood cell. ALCL ...

The lymphatic system is the network of vessels, tissues, and organs that are part of the body’s immune system. Lymphoma develops in infection-fighting cells called lymphocytes that circulate through ...

Lymphomas are cancers that develop in a type of white blood cell called a lymphocyte. They’re categorized into two broad categories called Hodgkin’s lymphoma (also known as Hodgkin’s disease, Hodgkin ...

Eye lymphoma, also known as ocular lymphoma, is a form of cancer of the eye. Eye lymphomas are very rare. One study in BMC Ophthalmology estimated that the most common kind of eye lymphoma (called ...

Pulmonary lymphoma is a rare cancer in which lymphoma cells affect your lungs. It can start inside the lungs (primary) or elsewhere in the body and spread to the lungs (secondary). Lymphoma occurs ...

Mary Ann Cornell was active and otherwise healthy when she received a diagnosis of diffuse large B cell lymphoma (DLBCL) at age 80, in the fall of 2019. When she learned she had this blood cancer, the ...

—The subtype of lymphoma and the timing of anticancer treatment was shown to directly affect the level of seroconversion in cancer patients administered COVID vaccination. Reviewed by Catherine E. Lai ...